6810 Stock Overview
Bio Preventive Medicine Corp, a clinical-staged biotech company, focusing on early detection and prevention of diseases. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Bio Preventive Medicine Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$28.55 |
| 52 Week High | NT$45.10 |
| 52 Week Low | NT$25.40 |
| Beta | 0 |
| 11 Month Change | -4.03% |
| 3 Month Change | -21.67% |
| 1 Year Change | -26.04% |
| 33 Year Change | -32.90% |
| 5 Year Change | n/a |
| Change since IPO | 22.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6810 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | 9.6% | -1.2% | -1.4% |
| 1Y | -26.0% | -0.8% | 26.5% |
Return vs Industry: 6810 underperformed the TW Biotechs industry which returned -0.8% over the past year.
Return vs Market: 6810 underperformed the TW Market which returned 26.5% over the past year.
Price Volatility
| 6810 volatility | |
|---|---|
| 6810 Average Weekly Movement | 6.1% |
| Biotechs Industry Average Movement | 4.2% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 6810 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6810's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | n/a | www.bpmbiotech.com |
Bio Preventive Medicine Corp, a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It provides DNlite test, a series of patented and clinically validated non-invasive urine test for diabetic kidney disease management, such as DNlite-IVD103 and DNlite-DN_Score.
Bio Preventive Medicine Corp. Fundamentals Summary
| 6810 fundamental statistics | |
|---|---|
| Market cap | NT$978.34m |
| Earnings (TTM) | NT$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 6810 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6810 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$0 |
| Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 6810 perform over the long term?
See historical performance and comparison